Abstract
Article type: Applied management review Author: Greg Wahlstrom, MBA, HCM Date: August 31, 2026 Estimated reading time: 27 minutes
Hospital boards are accountable for quality and organizational performance, yet they often receive fragmented, lagging, or weakly contextualized information about clinical and operational risk. This applied management review synthesizes 28 peer-reviewed sources to examine how governing bodies can move from passive metric review to active assurance. The evidence supports five linked governance practices: explicit ownership of a limited enterprise risk portfolio, clear decision rights and escalation thresholds, a balanced signal stack that combines outcomes with leading indicators and qualitative intelligence, recurring deep dives into selected risks, and closed-loop accountability for management action. The review translates those findings into a Board Assurance Operating System, a practical framework that connects committee work, management review, frontline learning, and board decisions without drawing directors into daily operations. Evidence quality is uneven and much of the literature is observational, cross-sectional, or setting-specific. Accordingly, the proposed operating model is an evidence-informed management synthesis, not a validated causal intervention. A 90-day implementation sequence and a measurement plan are provided for healthcare organizations seeking a more disciplined approach to oversight of clinical and operational performance risk.
Closed loop: verified learning resets the risk view and the next board decision.
Executive synthesis
A board can receive a polished quality report every month and still lack assurance. The difference is not the number of measures on the page. Assurance exists when directors can explain which risks matter most, why the signals are credible, what management is doing, whether the response is working, and when the board should intervene through governance rather than operations.
That standard is difficult to reach in healthcare. Clinical harm, staffing instability, capacity constraints, cyber exposure, compliance, emergency readiness, and financial pressure interact across professional and organizational boundaries. A delayed discharge can be a clinical risk, a workforce risk, a capacity risk, a patient-experience risk, and a financial risk at the same time. A favorable quarterly outcome can also conceal a deteriorating process if the board sees only lagging results. Conversely, a dashboard crowded with warnings can produce noise rather than insight when ownership, thresholds, and required decisions are unclear.
The peer-reviewed evidence does not identify one universally superior board structure. It does, however, point consistently toward a set of useful conditions. Boards that give sustained attention to quality, use explicit goals and benchmarks, engage clinical expertise, and connect executive accountability to performance appear better positioned to oversee care. National and international research also shows persistent gaps in board training, role clarity, resources, and the reliability of available indicators. Reviews of healthcare governance caution that much of the evidence is cross-sectional and context dependent, so association should not be mistaken for proof of causation.[1-6]
The practical implication is that boards need an operating system for assurance, not a larger dashboard. The proposed model begins with a limited portfolio of enterprise clinical and operational risks. Each risk has one accountable executive and one governing forum, and the board judges it through a balanced signal stack that combines outcomes, leading indicators, controls, and qualitative intelligence.
The operating discipline is completed through explicit decision rights, escalation thresholds, and exception rules established before a crisis. Focused deep dives test management’s claims and the reliability of controls, while a decision log records owners, deadlines, verification evidence, and residual risk so the board can confirm that action actually occurred.
The framework is a synthesis and management recommendation. It should be adapted to the organization’s regulatory environment, service portfolio, governance documents, data maturity, and risk appetite. It should not be presented as a statistically validated intervention or as a substitute for legal, regulatory, accreditation, clinical, cybersecurity, or financial advice.
Why conventional
board reporting can fail
Oversight can
be displaced by information volume
Hospital boards typically receive information through committee packets, dashboards, executive presentations, incident summaries, financial reports, and regulatory updates. More information can feel like stronger oversight, but volume is not the same as assurance. Directors may be unable to distinguish enterprise exposure from routine variation, or a measure that requires a decision from one that is included for awareness. If every measure is described as important, none is clearly prioritized.
Earlier United States research found that fewer than half of surveyed hospital board chairs ranked quality among their two highest priorities, and few reported dedicated training in quality.[25] Subsequent national work found that management practices, board attention to clinical quality, and effective use of metrics were associated with stronger performance on clinical quality measures.[22] A systematic narrative review of 122 papers similarly concluded that engaged and skilled boards, clear quality goals, and systematic use of data were promising practices, while also emphasizing that the field remained methodologically immature.[23]
These studies support a governance principle rather than a formula: board attention is a scarce resource. It should be allocated deliberately to a limited set of material risks and decisions. The inference is not that other measures disappear. Routine performance can remain available in appendices, committee materials, or digital drill-downs. The governing agenda, however, should make the most consequential exceptions and tradeoffs unmistakable.
Lagging outcomes
can create false reassurance
Mortality, serious safety events, readmissions, infections, grievances, turnover, and margin are important outcomes, but they often change after the underlying system has already deteriorated. A board that relies primarily on lagging measures may learn about risk after harm, disruption, or financial loss has occurred. It may also overreact to a single result that reflects random variation or a change in documentation rather than a true change in performance.
Operational studies provide examples of why leading and process measures matter. A quasi-experimental Lean intervention across 12 hospitals used visual dashboards, scheduling changes, operating policies, and governance structures. Some operating-room measures improved, including on-time starts, turnover time, and overruns, while utilization and procedure volume did not show significant improvement.[21] A hospital COVID-19 dashboard combined 14 daily measures to support leadership decisions in a fast-changing environment, but the report came from one organization and relied partly on leadership ratings.[15] These findings do not prove that dashboards improve outcomes. They do show that decision makers need a view of the process that produces the outcome and must interpret measures within their implementation context.
For board use, the inference is that every material risk should have more than one signal type. An outcome measure should be paired with at least one process or control measure and one source of contextual intelligence. For example, a workforce risk view might combine turnover and vacancy outcomes with schedule-fill reliability, premium labor dependence, orientation completion, safety reports, and structured feedback from clinical leaders. The exact measures are a local design choice, not a universal evidence-based set.
Ambiguous roles weaken
accountability
Governance becomes fragile when the board, its committees, the chief executive, and management teams hold different assumptions about ownership. Qualitative research in Dutch teaching hospitals found that governance committees could perform advisory, quality-control, and mediation roles, but that ambiguity in responsibilities and decision rights remained important.[5] A national survey of hospital managers in Iran found development needs across management competencies, with middle managers reporting lower confidence and formal training associated with higher self-rated competency.[4] Research on hospital accountability in Iran also identified centralization, unclear structures, and political pressure as barriers, although those findings are specific to that national context.[7]
United States evidence offers a different but related warning. A national survey of hospital equity officers found that many held broad accountability while reporting limited dedicated time, staffing, or budget.[6] The topic was equity leadership, not enterprise risk governance, but the organizational lesson is relevant: assigning accountability without authority and resources can create symbolic governance. A board should therefore ask not only who owns a risk, but also whether that owner controls the relevant processes, can convene cross-functional work, has adequate analytic support, and can escalate barriers.
Formal
structures do not guarantee effective behavior
Boards can establish a quality committee and still fail to challenge assumptions. They can add a clinician director and still lack clinical insight. They can receive benchmarked data and still focus on explanations rather than corrective action. A realist review of healthcare boards found mixed and sometimes contradictory evidence about board composition, while suggesting that diligence, strategic focus, monitoring, support, and context-sensitive behavior matter.[20]
An earlier study based on interviews with board chairs, chief executives, and chief nursing officers found substantial differences in how leaders perceived board engagement with nursing quality and patient safety. It highlighted the importance of bringing nursing knowledge into the boardroom.[28] Research linking a chief executive survey with United States quality data found better outcomes associated with practices such as a board quality committee, quality goals in the strategic plan, a standing quality agenda item, benchmarked dashboards, physician involvement, and executive evaluation tied to quality and safety.[26] More recent survey evidence from 13 Moroccan public hospitals found relationships between board attributes and selected operational outcomes, but not a strong association with mortality, reinforcing the need for caution.[13] Because these studies are observational, their findings should guide questions and design choices rather than be treated as causal prescriptions.
What the evidence supports
1. Treat risk
oversight as an enterprise portfolio
Clinical and operational risks should not be divided into isolated departmental lists that obscure interdependence. A proposed enterprise risk management model based on a systematic review and seven Brazilian hospital cases treated risk information as an input to governance and improvement decisions.[18] A more recent mixed-method study of private hospitals identified patient safety, sentinel events, staffing, cyber exposure, and litigation among prominent enterprise risks, while acknowledging the limits of a private-hospital and national context.[2] A literature review of Moroccan public hospitals likewise emphasized the need for a more integrated and rigorous risk-management approach.[3] Research in Greek public hospitals adds that weak formal risk-management guidance can limit the contribution of boards and internal audit, although that finding is context specific.[14]
The evidence supports viewing risk across the enterprise, but it does not determine the board’s final portfolio. The recommended practice is to identify a limited number of risks that meet locally defined materiality criteria. Criteria may include potential patient harm, legal or regulatory consequence, service interruption, financial exposure, strategic impact, reputational damage, speed of onset, and the organization’s ability to detect deterioration. Those criteria and any scoring scale are local governance assumptions that should be documented and approved.
A useful portfolio description is written as a risk statement rather than a topic label. “Workforce” is a topic. “Inability to sustain safe clinical capacity because critical roles cannot be recruited, scheduled, or retained” is a risk statement. The latter identifies the condition, consequence, and causal pathway that the board expects management to control.
2.
Connect every risk to ownership and a governing route
For each enterprise risk, the board should be able to identify one accountable executive, the management forum that reviews performance, the board committee with primary oversight, and the circumstances that move the issue to the full board. Shared work is unavoidable, but shared accountability can become no accountability if the final owner is unclear.
Tiered accountability has been proposed as a scalable structure for connecting governing-body expectations, executive responsibility, compliance, and a psychologically safe learning culture.[8] Evidence from quality governance also suggests that committee focus, strategic goals, metrics, and executive evaluation can reinforce oversight when they are aligned.[22,26] These findings justify an integrated accountability route, but the specific committee assignments and reporting cadence remain local design decisions.
The board should guard against two failure modes. The first is operational intrusion, in which directors attempt to manage staffing plans, individual incidents, or daily workflow. The second is passive delegation, in which the board accepts that a committee or executive “has it covered” without examining the basis for assurance. Good governance stays at the level of material risk, management capability, control effectiveness, resource tradeoffs, and accountability.
3. Build a balanced signal
stack
A signal stack gives the board several independent ways to judge a risk. It begins with outcomes—the harm, disruption, financial consequence, or strategic result the organization seeks to prevent or improve—and adds leading signals that show whether operating conditions are strengthening or deteriorating before the outcome changes.
Those measures should be tested against control reliability: whether required controls are present, used, and effective. They should also be interpreted alongside qualitative intelligence from patients, clinicians, employees, audits, complaints, whistleblowing, regulators, partners, and communities. Together, these sources give the board a more credible view than any single metric can provide.
Research on board performance supports the use of explicit goals, benchmarked dashboards, and management practices, but it also warns against overclaiming from associations.[22,23,25,26] Studies of nurse-manager dashboards emphasize the value of clear visualization, communication, and local ownership.[11] System-level case reports show how dashboards can align multiple entities around shared goals, but attribution is limited when the evidence comes from one organization.[12] A large quality-improvement initiative in the United States Veterans Health Administration used common tools and a dashboard to spread an age-friendly care model, while the authors called for further study of clinical impact.[10]
Qualitative intelligence is essential because not every risk appears first in a metric. A review of whistleblowing related to patient safety found that speaking-up behavior and organizational response were shaped by psychological safety and context; the literature was concentrated in nursing and a small number of countries.[19] Ethnographic research during the COVID-19 crisis described how hospital risk work combined numbers, expertise, and logistics rather than relying on a single information form.[16] A discrete-choice experiment involving 450 stakeholders in Flanders found preferences for independent external control, network-level improvement, mandatory reporting of severe incidents, and public quality indicators, illustrating that governance expectations also differ by stakeholder and policy context.[17] The governance inference is that a board should ask how it hears weak signals, dissenting views, and frontline concerns before they become validated trends.
4. Define thresholds as
decision rules
Red, yellow, and green colors are not governance unless they lead to predetermined questions or actions. A threshold should identify what changed, the period over which it changed, who validates the signal, what management must do, and when the board or committee is notified. Thresholds can be quantitative, qualitative, or event based.
Examples include a sustained decline in a leading measure, a control failure confirmed by audit, an emerging pattern across independent reports, an event with severe potential consequence, a missed remediation deadline, or a risk whose residual exposure exceeds a board-approved tolerance. These are recommended categories, not research-validated universal rules. Each organization must set thresholds using its own baseline variation, capacity, legal duties, clinical standards, and risk appetite.
The board should also define exception rules. A threshold can be overridden upward when a lower-frequency event has severe potential consequence, or downward when a data-quality problem makes an apparent signal unreliable. Overrides should be documented so that color changes do not become subjective negotiations.
5. Use deep dives to test
assurance
A deep dive is not a longer presentation. It is a structured examination of whether management understands a material risk and has reliable controls. The board or responsible committee should test five propositions:
- The risk statement and causal pathway are current.
- The selected signals are valid, timely, and resistant to manipulation.
- Controls are operating as described across relevant settings.
- Management action addresses causes rather than symptoms.
- Residual exposure and resource tradeoffs are explicit.
Deep dives should integrate clinical, operational, financial, technology, workforce, and patient perspectives as relevant. Research on extreme weather risk in hospital infrastructure demonstrated that hospital resilience depends on interdependencies with external infrastructure, emergency systems, health systems, and communities.[24] Research on connected medical-device risk similarly identifies data-security, privacy, and confidentiality exposure across the technology lifecycle.[9] A Bayesian study of clinical and operational risk illustrates the potential value of structured quantitative modeling while also reflecting the narrow and technical nature of the available evidence.[27] The practical conclusion is that a deep dive should follow the risk across boundaries rather than stop at the department that owns the dashboard.
6. Close the loop on board
decisions
Boards often document that a report was “received and discussed” without recording what changed as a result. Closed-loop assurance requires a decision or an explicit decision not to act, an accountable owner, a due date, the evidence needed to verify completion, and the effect on residual risk. A subsequent agenda should return to the item until the agreed evidence is accepted.
The loop should distinguish action completion from risk reduction. Installing a policy, purchasing technology, or completing training proves that an activity occurred. It does not prove that a control became reliable or an outcome improved. The verification step should therefore ask whether the intervention reached the intended setting, changed the relevant process, produced unintended consequences, and altered the board’s assessment of residual exposure.
The Board Assurance
Operating System
The proposed operating system converts the evidence into a repeatable governance rhythm. It is an inference from the literature and management practice, not a validated causal model.
Component 1: Enterprise
risk charter
The board approves a short charter that defines material clinical and operational risk, the relationship between enterprise risk management and quality oversight, committee responsibilities, escalation rules, and the distinction between governance and management. The charter should align with bylaws, committee charters, delegations of authority, legal duties, regulatory requirements, and accreditation obligations.
The charter should also state what assurance means. A practical definition is: sufficient, credible, and timely evidence that a material risk is understood, controlled within approved limits, and acted on when it moves outside those limits. That definition encourages inquiry into evidence quality rather than passive acceptance of a status label.
Component 2:
Risk register with causal pathways
Each board-level risk record should include the risk statement, material consequences, principal causes, control owners, affected populations and services, dependencies, current and target exposure, signal set, data limitations, escalation thresholds, and open actions. The board does not need every operational hazard. It needs the small number of risks whose potential consequences or cross-enterprise nature require governing attention.
The causal pathway is especially important. It gives directors a map for asking whether the leading measures and controls actually connect to the outcome. If the organization believes unsafe capacity is driven by vacancy, orientation delays, schedule instability, and turnover, the dashboard should not rely only on annual engagement and monthly vacancy. It should show the process by which those conditions affect safe coverage and patient care.
Component 3: Board signal
card
For each risk, a one-page signal card should answer seven questions:
- What is the risk and why is it material now?
- What changed since the last review?
- Which outcome, leading, control, and qualitative signals support that conclusion?
- How reliable and complete are the data?
- What is management doing, and is the response on schedule?
- What decision, endorsement, or challenge is required from the board?
- What would cause immediate escalation?
The card should display trends and thresholds in readable form and provide source, definition, frequency, owner, and limitations for each metric. The main page should not become a data dictionary. Detailed definitions can remain in an appendix or digital drill-down that is available to directors.
Component 4: Assurance
calendar
The annual board calendar should schedule recurring portfolio reviews and deeper examinations of selected risks. Timing should reflect risk velocity, seasonality, regulatory cycles, strategic decisions, capital planning, and known operational pressure. A fixed annual deep dive may be insufficient for a fast-moving cyber or capacity risk, while an emerging issue may require temporary monthly review.
The calendar should preserve space for unplanned risk. If every agenda is filled months in advance, weak signals and emerging exposure will compete with routine reports. A short standing segment for new or changing enterprise risks can make escalation normal rather than exceptional.
Component 5: Structured
challenge
Directors need a common method for testing assurance. Useful questions include:
- What evidence would make management change its current assessment?
- Which control is most important, and how do we know it works in practice?
- Where is performance variation greatest across sites, units, populations, or shifts?
- What does the aggregate result conceal?
- Which dependency sits outside the accountable executive’s direct control?
- What has been learned from staff, patients, complaints, audits, or near misses?
- What resource or policy tradeoff requires board action?
- If the plan fails, how soon will we know?
These questions do not imply distrust. They clarify the evidentiary basis for assurance and make productive challenge part of governance culture.
Component 6: Decision
and verification log
Every material board action should enter a log with the decision, rationale, accountable executive, milestones, due date, expected evidence, verification owner, and effect on residual risk. The responsible committee should review overdue or weakly evidenced actions. The full board should receive exceptions that exceed delegated authority or approved tolerance.
The log also creates institutional memory. Directors can see whether the same risk returns under a new label, whether temporary controls became permanent without evaluation, and whether resource commitments produced the expected operating change.
A practical board control
table
The following examples are recommendations to illustrate the operating model. They are not a universal metric set.
| Risk domain | Lagging outcome | Leading signal | Control evidence | Qualitative intelligence | Example board trigger |
|---|---|---|---|---|---|
| Patient safety | Serious harm or mortality pattern | Reliability of high-risk process steps | Audit of control use and exception closure | Patient stories, safety reports, speak-up themes | Severe event, repeated control failure, or deterioration beyond locally approved threshold |
| Workforce capacity | Harm, service disruption, turnover | Schedule-fill reliability, vacancy aging, orientation throughput |
Competency and coverage validation | Frontline leader and staff feedback | Sustained inability to staff critical services safely |
| Access and flow | Delays, cancellations, excess length of stay | Demand-capacity gap, discharge-barrier aging | Daily flow process reliability | Patient, physician, and partner feedback | Cross-service deterioration that threatens safety or strategic access |
| Cyber and connected devices | Data loss, downtime, patient-care disruption | Patch, identity, backup, and recovery readiness | Independent testing of critical controls | Incident reports and vendor-risk intelligence | Confirmed critical control failure or material threat escalation |
| Emergency resilience | Service interruption or facility loss | Readiness of dependencies and continuity resources | Exercise results and remediation closure | Community and infrastructure partner intelligence | Loss of a critical dependency or failed readiness exercise |
| Compliance and conduct | Enforcement, legal exposure, loss of trust | Reporting, investigation, and remediation timeliness | Independent compliance testing | Whistleblowing and culture signals | Retaliation concern, repeat violation, or overdue high-risk remediation |
A 90-day implementation
sequence
Days 1 to 30:
establish the governance foundation
The board chair, chief executive, chief clinical and operational leaders, enterprise risk lead, compliance leader, and governance support function should clarify the current route by which risks reach the board. The purpose is not to redesign every report. It is to identify fragmentation, duplication, missing ownership, and unclear escalation.
By day 30, leaders should have a practical governance foundation in place. That foundation includes a draft enterprise clinical and operational risk charter and a provisional portfolio limited to risks the board can examine meaningfully. Each risk should have a named accountable executive, a management forum, and a board committee. Leaders should also maintain an inventory of existing signals, definitions, owners, and known data limitations, while identifying any immediate assurance gaps that cannot wait for the full redesign.
The number of risks is deliberately not prescribed. The board should choose a portfolio small enough to govern and broad enough to represent material exposure.
Days 31 to 60:
build and test the signal cards
Management should build one-page signal cards for a small pilot group of risks. Each card should include the risk statement, causal pathway, outcome, leading, control, and qualitative signals, current actions, data limitations, and decision required. Directors and committee members should test whether the card supports a meaningful conversation without supplemental narration.
The pilot should include data validation. Metric owners should confirm definitions, source systems, update frequency, attribution rules, missing-data handling, and the potential for changes in documentation or coding to create false trends. The board should receive an explicit data-confidence statement rather than assume that every number has equal reliability.
Days 61 to 90:
run a deep dive and close the loop
The responsible committee should conduct one structured deep dive using the five assurance propositions. It should record decisions and verification requirements in the new log. The full board should then review the portfolio-level lessons: which signals were useful, which controls could not be verified, where ownership was weak, and what decisions require governing authority.
At day 90, the board should decide whether to expand the model, revise the charter, change committee responsibilities, invest in data or control capacity, or hold the pilot until identified weaknesses are addressed. A completed dashboard is not the success criterion. The criterion is whether the board made a better-informed decision and can verify the management response.
Measurement and evaluation
The operating system should be evaluated at three levels.
Governance process
Process measures can assess whether material risks have current owners, complete signal cards, defined thresholds, scheduled reviews, and closed-loop decisions. These measures demonstrate implementation, not effectiveness.
Assurance quality
The board can periodically rate whether information was timely, decision-relevant, balanced across signal types, transparent about limitations, and supported by verifiable control evidence. Independent governance review, internal audit, compliance, quality, or external assessment may strengthen confidence, depending on the risk and organizational structure.
Organizational effect
The organization should examine whether prioritized risks show improved control reliability, earlier detection, faster escalation, more durable remediation, or reduced harmful outcomes. Because many influences act simultaneously, causal attribution will be difficult. Interrupted time series, comparison groups, statistical process control, or staged implementation may strengthen evaluation when feasible, but the design should match local analytic capability and ethical constraints.
Boards should also monitor unintended effects. A narrow target can redirect effort away from unmeasured needs. Aggressive thresholds can encourage defensive reporting. A crowded risk portfolio can consume management attention without improving decisions. A healthy evaluation asks whether the governance system changes behavior in ways that improve or weaken learning.
Evidence boundaries
and local assumptions
The evidence base has important limitations. Reviews of hospital board oversight repeatedly describe a literature dominated by observational, cross-sectional, single-country, and self-reported studies.[20,23] Several recent sources used in this synthesis are qualitative studies, single-system cases, or management reports. They are useful for understanding mechanisms and implementation conditions but do not establish general causal effects. National governance structures, payment systems, regulatory duties, professional roles, and data infrastructure also vary substantially.
Leaders should distinguish four kinds of knowledge when applying this framework. Evidence refers to findings reported in the cited peer-reviewed studies. Cross-study inference describes conclusions that are consistent across multiple sources but have not been tested as a single intervention. The six-part Board Assurance Operating System and 90-day sequence are recommendations for executive use. The organization’s selected risk portfolio, thresholds, cadence, committee assignments, risk tolerance, metric definitions, and resource decisions remain local assumptions that must be documented and tested.
Organizations should document those local assumptions before implementation and reassess them when strategy, services, leadership, regulation, or the external environment changes.
Conclusion
The board’s task is not to manage the hospital. It is to ensure that management can recognize material clinical and operational risk, control it within approved limits, and respond when the evidence changes. That assurance cannot be created by a larger packet or a more colorful dashboard alone.
The available evidence favors sustained board attention to quality, explicit goals, meaningful clinical and operational expertise, balanced information, defined accountability, and disciplined follow-through. It also cautions that governance research remains context dependent and that many reported relationships are associative rather than causal. The Board Assurance Operating System translates those findings into a practical governance architecture while making its inferential status explicit.
The most useful first step is modest: select one material cross-enterprise risk, state it precisely, map its causal pathway, identify the accountable executive and governing route, test a balanced signal card, and record the board’s decision and verification evidence. If that process produces clearer challenge, faster recognition, and more reliable follow-through, the organization has begun to move from reporting performance to governing assurance.
References
- Kessler DP, Wygal W. Non-profit hospital governance, conduct, and CEO pay. Inquiry. 2025;62:1-12. doi:10.1177/00469580251366975.
- Sermhattakit A, Sae-Lim P. Key risks and mitigation strategies in enterprise risk management for private hospitals: a mixed-method study. Inquiry. 2025;62:1-13. doi:10.1177/00469580251347132.
- Oumghar A, Izza I. Risk management in Moroccan public hospitals: a literature review. Int J Health Care Qual Assur. 2025;38(1):1-27. doi:10.1108/IJHCQA-08-2023-0057.
- Liang Z, Kakemam E. Identifying competency development needs of hospital managers in Iran: a national survey. BMC Med Educ. 2025;25:122. doi:10.1186/s12909-025-06721-x.
- van der Baaren LM, et al. An exploration of governance in teaching hospitals in the Netherlands focused on educational objectives. BMC Med Educ. 2025;25:88. doi:10.1186/s12909-025-06680-3.
- Weissman JS, et al. The rise of the hospital chief equity officer: a national survey of early experiences and attributes. J Gen Intern Med. 2025;40(11):2523-2536. doi:10.1007/s11606-025-09453-2.
- Jalilvand MA, et al. Hospital governance accountability challenges in Iran: a qualitative study. BMC Health Serv Res. 2025;25:1-11. doi:10.1186/s12913-025-13100-1.
- Ibata B. Tiered accountability and elements of an effective compliance program within high reliability organizations. Front Health Serv Manage. 2025;41(3):5-13. doi:10.1097/HAP.0000000000000214.
- Khan N, Rudman RJ. IoT medical device risks: data security, privacy, confidentiality and compliance with HIPAA and COBIT 2019. S Afr J Bus Manag. 2025;56(1):1-17. doi:10.4102/sajbm.v56i1.4796.
- Schwartz AW, Jindal SK, Wozneak KA, Burke RE. Implementation of the Age-Friendly Health Systems Initiative in the Department of Veterans Affairs: 5 years of improving quality for older veterans. Inquiry. 2025;62:00469580251366883. doi:10.1177/00469580251366883.
- Young L, Johnson AH, Reeder BP, Vogelsmeier A. A picture worth a thousand words: insights from hospital nurse managers on dashboards to improve care at the bedside. Nurs Manage. 2025;56(2):43-49. doi:10.1097/NMG.0000000000000215.
- Ugwueke M, Jacobs P. Methodist Le Bonheur Healthcare: one health system’s journey to systemness. Front Health Serv Manage. 2025;42(1):6-14. doi:10.1097/HAP.0000000000000223.
- Mourajid Y, et al. Governance of healthcare quality: exploring the relationships between hospital board performance and healthcare quality outcomes. Int J Health Care Qual Assur. 2024;37(3-4):25-41. doi:10.1108/IJHCQA-09-2023-0065.
- Koutoupis AG, Koufopoulou P, Antonoglou D, Vozikis AP. Risk identification, assessment and management in the Greek public hospitals: the contribution of the board of directors and internal audit. J Account Manag Inf Syst. 2022;21(1):92-112. doi:10.24818/jamis.2022.01005.
- Gazivoda V, et al. CovidStats: development and implementation of a daily COVID-19 clinical dashboard in an urban teaching hospital. Qual Manag Health Care. 2022;31(4):259-266. doi:10.1097/QMH.0000000000000348.
- de Graaff B, Bal J, Bal R. Layering risk work amidst an emerging crisis: an ethnographic study of a hospital during the COVID-19 pandemic. Health Risk Soc. 2021;23(3-4):111-127. doi:10.1080/13698575.2021.1910210.
- Brouwers J, et al. The future of hospital quality of care policy: a multi-stakeholder discrete choice experiment in Flanders, Belgium. Health Policy. 2021;125(12):1565-1573. doi:10.1016/j.healthpol.2021.10.008.
- Etges APBS, de Souza JS, Kliemann Neto FJ, Felix EA. A proposed enterprise risk management model for health organizations. J Risk Res. 2019;22(4):513-531. doi:10.1080/13669877.2017.1422780.
- Blenkinsopp J, Snowden N, Mannion R, et al. Whistleblowing over patient safety and care quality: a review of the literature. J Health Organ Manag. 2019;33(6):737-756. doi:10.1108/JHOM-12-2018-0363.
- Chambers N, Harvey G, Mannion R. Who should serve on health care boards? What should they do and how should they behave? A fresh look at the literature and the evidence. Cogent Bus Manag. 2017;4(1). doi:10.1080/23311975.2017.1357348.
- Hassanain M, Zamakhshary M, Farhat G, Al-Badr A. Use of Lean methodology to improve operating room efficiency in hospitals across the Kingdom of Saudi Arabia. Int J Health Plann Manage. 2017;32(2):133-146. doi:10.1002/hpm.2334.
- Tsai TC, Jha AK, Gawande AA, Huckman RS, Bloom N, Sadun R. Hospital board and management practices are strongly related to hospital performance on clinical quality metrics. Health Aff. 2015;34(8):1304-1311. doi:10.1377/hlthaff.2014.1282.
- Millar R, Mannion R, Freeman T, Davies HTO. Hospital board oversight of quality and patient safety: a narrative review and synthesis of recent empirical research. Milbank Q. 2013;91(4):738-770. doi:10.1111/1468-0009.12032.
- Loosemore M, Carthey J, Chandra V, Chand AM. Modelling the risks of extreme weather events for Australasian hospital infrastructure using rich picture diagrams. Constr Manag Econ. 2012;30(12):1071-1086. doi:10.1080/01446193.2012.725941.
- Jha AK, Epstein AM. Hospital governance and the quality of care. Health Aff. 2010;29(1):182-187. doi:10.1377/hlthaff.2009.0297.
- Jiang HJ, Lockee C, Bass K, Fraser I. Board oversight of quality: any differences in process of care and mortality? J Healthc Manag. 2009;54(1):15-30.
- Cornalba C. Clinical and operational risk: a Bayesian approach. Methodol Comput Appl Probab. 2009;11(1):47-63. doi:10.1007/s11009-007-9068-9.
- Mastal MF, Joshi M, Schulke K. Nursing leadership: championing quality and patient safety in the boardroom. Nurs Econ. 2007;25(6):323-330.
Disclaimer
This article is provided for education and general management discussion. It does not constitute legal, regulatory, accreditation, clinical, cybersecurity, financial, or other professional advice. Healthcare organizations should evaluate recommendations against their governing documents, applicable requirements, local evidence, and qualified professional guidance.
